PVC Blisters Fight Back in Plastics Today

When a recent article suggested that polypropylene (PP) blister packs could replace polyvinyl chloride (PVC) in pharmaceutical packaging, the PVCMed Alliance had to respond. PVC blister packs, the backbone of pharmaceutical packaging, are not just enduring — they’re evolving to meet future demands. Read full comment in Plastics Today.

The Gold Standard in Pharmaceutical Packaging

PVC blister packs dominate the pharmaceutical market, particularly in Europe, where they account for approximately 95% of blister packaging. This isn’t by chance. PVC, often combined with PVDC and aluminum, offers exceptional protection against moisture and oxygen, extending the shelf life of sensitive medications. Its proven performance is supported by tthe European Chemicals Agency, which recognises PVC’s critical role in healthcare packaging and medical devices.

Recycling Innovation and Mono-PVC Solutions

Despite misconceptions, PVC blister packs are recyclable. The VinylPlus PharmPack initiative is pioneering recycling technologies to recover and reuse materials from PVC-based blister packs.

In addition to advancing recycling methods, mono-PVC blister packs are emerging as a viable alternative. These solutions streamline recycling by reducing the need for material separation while maintaining the protective properties PVC is known for.

In Australia, programs like Pharmacycle are setting global benchmarks by collecting and recycling PVC blister packs, transforming them into high-quality products. These initiatives show that PVC is not just sustainable in its current use but is continuously innovating to meet environmental challenges.

PVC: Adapting for a Sustainable Future

PVC blister packs are more than a legacy product; they are a forward-looking solution. Whether through enhanced recycling systems or mono-PVC innovations, PVC continues to meet the high standards of the pharmaceutical industry while aligning with sustainability goals.